Your browser doesn't support javascript.
loading
Changes in asthma drug therapy costs for patients receiving chronic montelukast therapy in the U.K.
Price, D B; Ben-Joseph, R H; Zhang, Q.
Affiliation
  • Price DB; Department of General Practice & Primary Care, University of Aberdeen, Foresterhill Health Centre, Scotland, UK. d.price@abdn.ac.uk
Respir Med ; 95(1): 83-9, 2001 Jan.
Article in En | MEDLINE | ID: mdl-11207023
Subject(s)
Search on Google
Print
XML
PubMed Links

Collection: 01-internacional Health context: 11_ODS3_cobertura_universal / 1_ASSA2030 Database: MEDLINE Main subject: Quinolines / Asthma / Drug Costs / Anti-Asthmatic Agents / Albuterol / Acetates Type of study: Health_economic_evaluation / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Respir Med Year: 2001 Document type: Article
Search on Google
Print
XML
PubMed Links

Collection: 01-internacional Health context: 11_ODS3_cobertura_universal / 1_ASSA2030 Database: MEDLINE Main subject: Quinolines / Asthma / Drug Costs / Anti-Asthmatic Agents / Albuterol / Acetates Type of study: Health_economic_evaluation / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Respir Med Year: 2001 Document type: Article